Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Foot Muscles Training in Sclerosis [NA]
A recruiting clinical trial is evaluating foot muscle training for individuals with multiple sclerosis and muscle weakness. Sponsored by Iné…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Stratification of Risks of Conversion of Radiologically Isolated Syndromes (RIS) by Identifying Biomarkers in Serum and Cerebrospinal Fluid.
A clinical trial update about identifying biomarkers in blood and cerebrospinal fluid to stratify the risk of conversion from radiologically…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System [EARLY_Phase 1]
An early-phase clinical trial is investigating CT103A cell therapy for relapsed/refractory antibody-associated inflammatory diseases of the …
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis [NA]
A clinical trial titled Technology-assisted Conscientiousness Therapy for People With Multiple Sclerosis has completed, sponsored by the Sta…
-
CLINICAL_TRIALS trial_result · 2024-10-28Clinical Trial Update: Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
A completed clinical trial evaluating upper-extremity function in advanced multiple sclerosis patients treated with ocrelizumab (Ocrevus) an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Voluntary Activation During Isokinetic Contractions in Subjects with Neuromotor Disorders [NA]
A clinical trial sponsored by Istituto Auxologico Italiano is evaluating voluntary activation during isokinetic contractions in individuals …
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Walking and Thinking - Brain Activity During Complex Walking in People With Multiple Sclerosis
A completed clinical trial entry from Karolinska Institutet examining brain activity during complex walking (dual-task walking) in people wi…
-
CLINICAL_TRIALS research · 2024-10-23Clinical Trial Update: Effects of Individualized Training to Reduce Fatigue in Patients With Newly and Advanced Diagnosed Multiple Sclerosis [NA]
This clinical trial assesses whether individualized training reduces fatigue in patients with newly diagnosed or advanced multiple sclerosis…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Application of Multiparametric Structural and Functional MRI in Unraveling the Substrates of Cognitive Impairment and Disability in Multiple Sclerosis
A clinical trial update on using multiparametric structural and functional MRI to understand cognitive impairment and disability in Multiple…
-
CLINICAL_TRIALS trial_result · 2024-10-22Clinical Trial Update: Mood Disorders in Multiple Sclerosis Patients
This clinical trial update confirms that a study evaluating mood disorders in patients with multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Improving Prospective Memory Via Telehealth [NA]
A completed clinical trial evaluated a telehealth approach to improve prospective memory in people with multiple sclerosis, with results pos…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis [EARLY_Phase 1]
Clinical trial update for an early-phase 1 study of oral fecal microbiota transplant in people with Multiple Sclerosis.
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis [NA]
This is a completed clinical trial evaluating the feasibility of frame running as an exercise option for people with Multiple Sclerosis, spo…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Adderall XR and Cognitive Impairment in MS [Phase 2, Phase 3]
This update describes a Phase 2/Phase 3 clinical trial evaluating Adderall XR for cognitive impairment in individuals with multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: The Effect of Self Acupressure in Patients With Multiple Sclerosis [NA]
The study on self acupressure for multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Real-World Persistence and Adherence of Ofatumumab Compared to Self-Injectable and Oral DMTs in Patients With Multiple Sclerosis
Real-world analysis comparing persistence and adherence to Ofatumumab versus self-injectable and oral disease-modifying therapies in multipl…
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Psychometric Evaluation in Patients With Brain Damage During Neuroinflammation
A clinical trial update describing a psychometric evaluation in patients with brain damage during neuroinflammation, with enrollment by invi…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Effects of Dimethyl Fumarate on Cognitive Performance and Brain Abnormalities in Multiple Sclerosis.
The completed clinical trial evaluated the effects of Dimethyl Fumarate on cognitive performance and brain abnormalities in individuals with…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Propionic Acid in Multiple Sclerosis [Phase 2, Phase 3]
Phase 2 and Phase 3 trial of propionic acid for multiple sclerosis has completed.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Investigation of the Effect of Ocrelizumab on Peripheral Lymphocyte Immunophenotypes with Suppressive Capacity in MS
A clinical trial investigates the effect of ocrelizumab on peripheral lymphocyte immunophenotypes and their suppressive capacity. The study …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Investigating Visuo-spatial Abilities and Psychological Effects in West Nile and Multiple Sclerosis Patients with a Focus on a Possible Rehabilitation Protocol [NA]
Clinical trial sponsored by IRCCS San Camillo in Venice, Italy, is recruiting to evaluate visuo-spatial abilities and psychological effects …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Functional Electrostimulation on the Upper Lip in Multiple Sclerosis [NA]
Clinical trial update indicates a study on functional electrostimulation of the upper lip in multiple sclerosis is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Validation of the 18 kiloDalton Translocator Protein (TSPO) as a Novel Neuroimmunodulatory Target [NA]
A clinical trial is validating TSPO as a novel neuroimmunomodulatory target for multiple sclerosis. The study is currently recruiting.
-
FDA approval · 2024-10-11FDA Approved: DIMETHYL FUMARATE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for dimethyl fumarate from Ascend Laboratories, LLC, indicating regulatory clearance for a suppl…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: The Effect of the Human Care Model on Patients With Multiple Sclerosis [NA]
Clinical trial update evaluating the effect of a Human Care Model on patients with Multiple Sclerosis; the status of the trial is unknown.